<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03064672</url>
  </required_header>
  <id_info>
    <org_study_id>BALLOONGBS- HMO-CTIL</org_study_id>
    <nct_id>NCT03064672</nct_id>
  </id_info>
  <brief_title>Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial</brief_title>
  <official_title>Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective cohort study aims to determine whether maternal and neonatal outcomes are
      affected by GBS carrier status in women undergoing transcervical balloon catheter insertion.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>adverse neonatal outcomes</measure>
    <time_frame>2-3 days</time_frame>
    <description>the incidence of composite adverse neonatal outcomes based on the NICE criteria for early detection of neonatal sepsis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>composite adverse maternal outcomes</measure>
    <time_frame>2-3 days</time_frame>
    <description>chorioamnionitis, suspected chorioamnionitis or endometritis, urinary tract infection or sepsis in the peripartum period, prolonged hospital stay, and allergic reaction to antibiotics</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Transcervical Balloon Catheter Insertion in GBS Positive Women</condition>
  <arm_group>
    <arm_group_label>induction by transcervical Balloon Catheters insertion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>induction without transcervical Balloon Catheters</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcervical Balloon Catheters</intervention_name>
    <description>induction of labor by transcervical Balloon Catheters insertion</description>
    <arm_group_label>induction by transcervical Balloon Catheters insertion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  During the study period and in the absence of contraindications, women anticipating
             induction of labor with unripe cervix will be screened for eligibility.

          -  Inclusion criteria are singleton gestation with confirmed cephalic presentation

          -  Gestational age between 37+0/7 and 41+6/7 weeks'

          -  Intact membranes

          -  Reactive non-stress test and Bishop's score &lt; 6.

        Exclusion Criteria:

          -  Women less than 18 years, with multiple gestation pregnancies, pregnancies with major
             fetal anomalies, vaginal infection, intrauterine fetal death and those who were not
             candidates for vaginal delivery (placenta previa, non-cephalic presentation, planned
             cesarean delivery).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Doron Kabiri, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Myriam Safrai, MD</last_name>
    <email>myriamsafrai@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hadas Lemberg,, PhD</last_name>
    <email>lhadas@hadassah.org.il</email>
  </overall_contact_backup>
  <reference>
    <citation>Kabiri D, Hants Y, Yarkoni TR, Shaulof E, Friedman SE, Paltiel O, Nir-Paz R, Aljamal WE, Ezra Y. Antepartum Membrane Stripping in GBS Carriers, Is It Safe? (The STRIP-G Study). PLoS One. 2015 Dec 31;10(12):e0145905. doi: 10.1371/journal.pone.0145905. eCollection 2015.</citation>
    <PMID>26719985</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2017</study_first_submitted>
  <study_first_submitted_qc>February 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2017</study_first_posted>
  <last_update_submitted>February 24, 2017</last_update_submitted>
  <last_update_submitted_qc>February 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data of the mother and the baby will be checked and recorded. At the end of the study, all the data are gonna be analyzed. In case of a severe bad outcome, the data will be checked during the study to make sure that the study is not the cause.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

